Resultaterne fra regressionsanalyser af farmakokinetiske data tyder på, at samtidig administration af dexamethason og CANCIDAS kan medføre klinisk betydningsfulde fald i dalkoncentrationer af caspofungin hos børn.
In paediatric patients, results from regression analyses of pharmacokinetic data suggest that co-administration of dexamethasone with CANCIDAS may result in clinically meaningful reductions in caspofungin trough concentrations.